adrenaline (epinephrine) acid tartrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ADRENALINE-LINK 1:1,000 1mg/1mL adrenaline (epinephrine) acid tartrate injection BP ampoule
AUST R: 12048
Active ingredients:
adrenaline (epinephrine) acid tartrate

Dosage form:
Injection, solution

Sponsor:
Link Medical Products Pty Ltd T/A Link Pharmaceuticals

Phone:
1800 181 060

From
09 Dec 2024
to
14 Mar 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
The sponsor is working to expedite the next shipment. Alternative brand is available.

ADRENALINE-LINK 1:10,000 1mg/10mL adrenaline (epinephrine) acid tartrate injection BP pre filled syringe
AUST R: 210672
Active ingredients:
adrenaline (epinephrine) acid tartrate

Dosage form:
Injection, solution

Sponsor:
Link Medical Products Pty Ltd T/A Link Pharmaceuticals

Phone:
1800181060

From
06 Aug 2024
to
24 Jan 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
The sponsor is working to expedite the next shipment. Other dosage forms are available.

2% XYLOCAINE DENTAL WITH ADRENALINE 1:80,000 2.2mL injection cartridge
AUST R: 12024
Active ingredients:
adrenaline (epinephrine) acid tartrate
lidocaine hydrochloride monohydrate

Dosage form:
Injection, solution

Sponsor:
Dentsply Sirona Pty Ltd

Phone:
1300552929

From
15 Jan 2025
to
16 Feb 2025

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
Sponsor is closely controlling the supply

ADRENALINE JUNO 1:10,000 adrenaline (epinephrine) (as acid tartrate) 1 mg/10 mL solution for injection prefilled syringe
AUST R: 282377
Active ingredients:
adrenaline (epinephrine) acid tartrate

Dosage form:
Injection, solution

Sponsor:
Juno Pharmaceuticals Pty Ltd

Phone:
0388881288

From
02 Oct 2024
to
03 Dec 2024

Shortage status:
Resolved

Availability:
Available

Reason:
Unexpected increase in demand due to other sponsors unable to supply

BUPIVADREN Bupivacaine 0.5% w/v with Adrenaline (epinephrine) 1:200,000 injection solution vial
AUST R: 292528
Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride monohydrate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
31 Jan 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.

XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 12008
Active ingredients:
adrenaline (epinephrine) acid tartrate
lidocaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

Deletion from market:
12 Aug 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Products are available in another presentation.